Davis George Eric — SEC insider filings

SEC reporting owner CIK 1380710. 29 insider filings on record with FilingPulse; latest filed 2026-09-03.

Transaction summary — filings shown

Covers all 29 filings on record, filed 2021-03-17 to 2026-09-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
BIOMARIN PHARMACEUTICAL INC (BMRN)EVP, Chief Legal Officer29—17 legs · 228,674 sh · $18,749,58955

Insider filings — Davis George Eric

FiledFormIssuerReported transactionsSource
2026-09-034BIOMARIN PHARMACEUTICAL INC (BMRN)Sale (S): 17,557 @ $66.28EDGAR
2026-03-194BIOMARIN PHARMACEUTICAL INC (BMRN)Tax withholding (F): 1,273 @ $56.05EDGAR
2026-03-174BIOMARIN PHARMACEUTICAL INC (BMRN)Tax withholding (F): 7,177 @ $58.51 · Grant/award (A): 14,570 @ $0 · Grant/award (A): 34,690 (derivative) @ $0EDGAR
2026-02-264BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 6,177 @ $0 · Grant/award (A): 6,675 @ $0 · Grant/award (A): 2,372 @ $0 · Sale (S): 26,061 @ $61.36EDGAR
2025-03-184BIOMARIN PHARMACEUTICAL INC (BMRN)Tax withholding (F): 16,249 @ $69.44 · Grant/award (A): 12,940 @ $0 · Grant/award (A): 30,020 (derivative) @ $0EDGAR
2025-02-274BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 11,040 @ $0 · Grant/award (A): 9,660 @ $0 · Grant/award (A): 9,367 @ $0EDGAR
2024-05-304BIOMARIN PHARMACEUTICAL INC (BMRN)Option exercise (M): 40,850 @ $63.10 · Sale (S): 38,071 @ $74.45 · Sale (S): 2,779 @ $75.29 · Option exercise (M): 40,850 (derivative) @ $0EDGAR
2024-05-064BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 301 @ $68.65 · Option exercise (M): 1,850 @ $63.10 · Sale (S): 1,850 @ $85.01 · Option exercise (M): 1,850 (derivative) @ $0EDGAR
2024-04-014BIOMARIN PHARMACEUTICAL INC (BMRN)Sale (S): 24,602 @ $88.34EDGAR
2024-03-194BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 10,260 @ $0 · Tax withholding (F): 21,699 @ $83.87 · Grant/award (A): 22,990 (derivative) @ $0EDGAR
2024-02-294BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 20,840 @ $0 · Grant/award (A): 9,063 @ $0 · Grant/award (A): 6,284 @ $0EDGAR
2023-12-144BIOMARIN PHARMACEUTICAL INC (BMRN)Sale (S): 13,764 @ $95.30EDGAR
2023-08-094BIOMARIN PHARMACEUTICAL INC (BMRN)Sale (S): 11,000 @ $89.42EDGAR
2023-05-184BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 317 @ $66.88 · Gift (G): 210 @ $0EDGAR
2023-03-174BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 8,900 @ $0 · Tax withholding (F): 3,025 @ $87.74 · Tax withholding (F): 19,957 @ $93.41 · Grant/award (A): 20,320 (derivative) @ $0EDGAR
2023-03-024BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 20,200 @ $0 · Grant/award (A): 10,100 @ $0 · Grant/award (A): 7,424 @ $0EDGAR
2023-02-284BIOMARIN PHARMACEUTICAL INC (BMRN)Option exercise (M): 1,474 @ $67.81 · Option exercise (M): 1,474 (derivative) @ $0EDGAR
2022-08-114BIOMARIN PHARMACEUTICAL INC (BMRN)Sale (S): 3,690 @ $96.34 · Option exercise (M): 47,526 @ $67.81 · Sale (S): 47,526 @ $95.93 · Option exercise (M): 47,526 (derivative) @ $0EDGAR
2022-07-114BIOMARIN PHARMACEUTICAL INC (BMRN)Sale (S): 7,398 @ $90EDGAR
2022-05-044BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 341 @ $62.41 · Option exercise (M): 15,347 @ $37.46 · Sale (S): 15,347 @ $80.38 · Option exercise (M): 15,347 (derivative) @ $0EDGAR
2022-04-274BIOMARIN PHARMACEUTICAL INC (BMRN)Option exercise (M): 2,669 @ $37.46 · Option exercise (M): 2,669 (derivative) @ $0EDGAR
2022-03-234BIOMARIN PHARMACEUTICAL INC (BMRN)Sale (S): 6,129 @ $81.29EDGAR
2022-03-174BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 11,040 @ $0 · Tax withholding (F): 8,290 @ $78.27 · Tax withholding (F): 1,252 @ $80.72 · Grant/award (A): 26,520 (derivative) @ $0EDGAR
2022-03-104BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 9,370 @ $0EDGAR
2021-08-044BIOMARIN PHARMACEUTICAL INC (BMRN)Sale (S): 5,518 @ $76.69EDGAR
2021-05-044BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 341 @ $62.41 · Sale (S): 2,584 @ $78.30 · Sale (S): 2,089 @ $78.30EDGAR
2021-04-204BIOMARIN PHARMACEUTICAL INC (BMRN)Option exercise (M): 2,709 @ $26.49 · Sale (S): 2,709 @ $79.58 · Option exercise (M): 2,709 (derivative) @ $0EDGAR
2021-03-234BIOMARIN PHARMACEUTICAL INC (BMRN)Tax withholding (F): 1,391 @ $78.52EDGAR
2021-03-174BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 10,420 @ $0 · Tax withholding (F): 5,014 @ $78.39 · Tax withholding (F): 1,252 @ $77.21 · Grant/award (A): 25,650 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-03-15 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1380710 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs